Femoral intertrochanteric fracture
Conditions
Interventions
Liposomal bupivacaine group:Fascia iliaca block will be performed with liposomal bupivacaine at a dose of 133mg/30mL
Ropivacaine group:Fascia iliaca block will be performed with ropivacaine at a dose of 60mg/30mL
Sponsors
Sichuan Provincial Orthopedic Hospital
Eligibility
Sex/Gender
All
Age
65 Years to 90 Years
Inclusion criteria
Inclusion criteria: Patients with unilateral femoral intertrochanteric fracture, ASA grade I-III, age range from 65 to 90 years old.
Exclusion criteria
Exclusion criteria: Multiple trauma, multiple fractures, or other fractures that do not meet the inclusion criteria, such as pathological fractures, pelvic fractures, and old fractures; Those who do not understand or refuse the test method; Individuals who are allergic to any medication ingredient; Individuals with cognitive impairment [using the Mini Mental State Examination (MMSE) with a score of<24]; Individuals who have received pain treatment within 24 hours prior to the trial; Patients with an expected waiting time for surgery of less than 24 hours determined by multidisciplinary evaluation in the emergency room; Patients with contraindications to surgery or anesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The motor VAS score at 24 hours after iliac fascia block treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dosage of analgesic drugs;Delirium incidence rate;sleep quality and anxiety;VAS scores at other time points;Rebound Pain;Complications during hospitalization;Clinical outcome 30 days after surgery; | — |
Countries
China
Contacts
Public ContactQin Zhijun
Sichuan Provincial Orthopedic Hospital
Outcome results
None listed